Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Pulmonary DiseaseChronic ObstructiveHypercapniaHypoxemiaArrhythmias, Cardiac
Interventions
DRUG

supplementary oxygen

Supplementary oxygen 2 L/min if SpO2 \< 90%. If SpO2 \< 90 % the oxygen dose is titrated until SpO2 reads 88-92%. For patients on LTOT the oxygen dose is doubled for intervention.

DRUG

zopiclone

5 mg sedative given approximately 1 hour before sleep

OTHER

alcohol

5 mg alcohol/kg body-weight approximately 1 hour before sleep

Trial Locations (2)

1485

Glittreklinikken, Hakadal

Glittreklinikken, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Stiftelsen Helse og Rehabilitering

OTHER

collaborator

Landsforeningen for hjerte og lungesyke (LHL)

UNKNOWN

collaborator

University Hospital, Akershus

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

ResMed

INDUSTRY

lead

LHL Helse

OTHER